Although a number of mutations/variants in the EGFR gene have been demonstrated to be associated with the development and metastasis of lung cancer (9,10), it remains largely unclear whether -216G/T, a functional variant in the EGFR promoter, has any critical role in the pleural metastasis of lung adenocarcinoma. This evidence concerns the gene EGFR and lung cancer.